Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm open-label study of human fibrin sealant for hemostasis in burn wound eschar excision or skin donor sites
CTR20210638Phase 2Active
- Sponsor
- Shandong Taibang Biological Products
- Start
- Apr 2021
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of tachosil in burn injury, sponsored by Shandong Taibang Biological Products. Started Apr 2021; status: active.
02
Drugs
tachosil
03
Conditions
burn injury
Beyond the preview
Go deeper on CTR20210638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210638.